Psoriasis is a chronic, inflammatory disorder that affects both the skin and joints, and is mediated by the immune system. Its global prevalence varies regionally, ranging from 0.14%–1.99%. A database study reported a 0.34% estimated occurrence of psoriasis in Japan. The paradigm shift has occurred...
Psoriasis is an inflammatory skin disease that seriously affects the physical and mental health of humans. Some patients may also be accompanied by severe itching. It is commonly associated with genetics, immune disorders, infections, environmental factors, and endocrine factors. It is reported that...
The use of the current available therapies for psoriasis management may sometimes be limited by reduced patients' compliance, safety issues for patients' comorbidities, primary lack of efficacy, loss of effectiveness, development of side effects. In this context, several clinical trials investigating...
Approximately 3.0% of the United States (U.S.) adult population suffers from psoriasis, a prevalent immune-mediated disease [1]. The incidence of psoriasis is comparable in women and men. The two peak age ranges for psoriasis are 18 to 39 and 50 to 69 years, although it can develop at any age [2]. It...
Nail psoriasis is a common manifestation of psoriasis that causes changes in the nail, including pitting, leukonychia, subungual hyperkeratosis, and onycholysis. Nail psoriasis is clinically significant, as its presence is often associated with the development of psoriatic arthritis, making its accurate...